Gaiqin Pei1,2, Yi Tang1, Li Tan2, Jiaxing Tan2, Long Ge3, Wei Qin4. 1. Division of Nephrology, Department of Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. 2. West China School of Medicine, Sichuan University, Chengdu, Sichuan, China. 3. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China. 4. Division of Nephrology, Department of Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. ddqstrike@163.com.
Abstract
PURPOSE: Patients with chronic kidney disease (CKD) are frail and have high risk of cardiovascular disease. This study was performed to assess the effects of aerobic exercise training in adults with CKD. METHODS: MEDLINE, EMBASE, CENTRAL, Web of Science were searched up to December 2018 to identify eligible randomized controlled trials (RCTs) that studied aerobic exercise in adults with CKD. Primary outcomes include oxygen consumption at peak exercise (VO2 peak), exercise capacity, blood pressure, heart rate, and health-related quality of life (HRQoL). Statistical analysis was performed using Review Manager 5.2.1 software. RESULTS: Thirty-one trials, containing 1305 adults with CKD, were included. The most used aerobic exercise program was characterized as moderate intensity (15/31), 3 times/week frequency (22/31), 30 min duration (9/31) and 3 months follow-up (12/31). Significant improvement was observed in cardiorespiratory function (VO2 peak) (P < 0.0001), exercise duration (P < 0.0001), HDL-C (P = 0.03) and pain (P = 0.007), physical role (P = 0.03), general health (P = 0.007) of HRQoL after aerobic exercise in patients with CKD. A marginal difference was observed in HR max (P = 0.07). However, no statistical difference was noticed in exercise capacity, blood pressure, resting heart rate, serum lipid and serum creatinine between aerobic training group and control. No subgroup differences were altered in all outcomes when studies were divided based on intensity of exercise training, the treatment of dialysis or the length of intervention. CONCLUSIONS: Aerobic exercise training could benefit adult CKD patients in increasing cardiorespiratory function, exercise duration, HDL-C level and improve health quality of life.
PURPOSE:Patients with chronic kidney disease (CKD) are frail and have high risk of cardiovascular disease. This study was performed to assess the effects of aerobic exercise training in adults with CKD. METHODS: MEDLINE, EMBASE, CENTRAL, Web of Science were searched up to December 2018 to identify eligible randomized controlled trials (RCTs) that studied aerobic exercise in adults with CKD. Primary outcomes include oxygen consumption at peak exercise (VO2 peak), exercise capacity, blood pressure, heart rate, and health-related quality of life (HRQoL). Statistical analysis was performed using Review Manager 5.2.1 software. RESULTS: Thirty-one trials, containing 1305 adults with CKD, were included. The most used aerobic exercise program was characterized as moderate intensity (15/31), 3 times/week frequency (22/31), 30 min duration (9/31) and 3 months follow-up (12/31). Significant improvement was observed in cardiorespiratory function (VO2 peak) (P < 0.0001), exercise duration (P < 0.0001), HDL-C (P = 0.03) and pain (P = 0.007), physical role (P = 0.03), general health (P = 0.007) of HRQoL after aerobic exercise in patients with CKD. A marginal difference was observed in HR max (P = 0.07). However, no statistical difference was noticed in exercise capacity, blood pressure, resting heart rate, serum lipid and serum creatinine between aerobic training group and control. No subgroup differences were altered in all outcomes when studies were divided based on intensity of exercise training, the treatment of dialysis or the length of intervention. CONCLUSIONS: Aerobic exercise training could benefit adult CKDpatients in increasing cardiorespiratory function, exercise duration, HDL-C level and improve health quality of life.
Authors: Amaryllis H Van Craenenbroeck; Emeline M Van Craenenbroeck; Katrijn Van Ackeren; Christiaan J Vrints; Viviane M Conraads; Gert A Verpooten; Evangelia Kouidi; Marie M Couttenye Journal: Am J Kidney Dis Date: 2015-05-08 Impact factor: 8.860
Authors: Karsten Vanden Wyngaert; Amaryllis H Van Craenenbroeck; Wim Van Biesen; Annemieke Dhondt; Anouk Tanghe; Ans Van Ginckel; Bert Celie; Patrick Calders Journal: PLoS One Date: 2018-09-11 Impact factor: 3.240
Authors: Luke A Baker; Daniel S March; Thomas J Wilkinson; Roseanne E Billany; Nicolette C Bishop; Ellen M Castle; Joseph Chilcot; Mark D Davies; Matthew P M Graham-Brown; Sharlene A Greenwood; Naushad A Junglee; Archontissa M Kanavaki; Courtney J Lightfoot; Jamie H Macdonald; Gabriella M K Rossetti; Alice C Smith; James O Burton Journal: BMC Nephrol Date: 2022-02-22 Impact factor: 2.388
Authors: Kassia S Beetham; Rathika Krishnasamy; Tony Stanton; Julian W Sacre; Bettina Douglas; Nicole M Isbel; Jeff S Coombes; Erin J Howden Journal: J Am Soc Nephrol Date: 2021-12-10 Impact factor: 10.121
Authors: Sharlene A Greenwood; Pelagia Koufaki; Jamie H Macdonald; Catherine Bulley; Sunil Bhandari; James O Burton; Indranil Dasgupta; Kenneth Farrington; Ian Ford; Philip A Kalra; Mick Kumwenda; Iain C Macdougall; Claudia-Martina Messow; Sandip Mitra; Chante Reid; Alice C Smith; Maarten W Taal; Peter C Thomson; David C Wheeler; Claire White; Magdi Yaqoob; Thomas H Mercer Journal: Health Technol Assess Date: 2021-06 Impact factor: 4.014